Corporate History

1990’s

Byotrol’s first antimicrobial technology was invented and patented

2005

The company was floated on the UK AIM stock market

2007

Byotrol Consumer Products set up in joint venture with Byotrol plc and WhatIf Ventures

2010

First consumer hand sanitiser launched in Boots

2011

Consumer household surface care range launched in Tesco

2013

Byotrol plc acquires remaining share of Byotrol Consumer Products Ltd from WhatIf Ventures

2014

Actizone patent granted in the UK

2016

PAS 2424 long-lasting antimicrobial test method developed in conjunction with the BSI

2017

Byotrol acquired Winch Pharma Consumer Healthcare Ltd, giving Byotrol immediate access to the NHS Supply Chain framework for new INVIRTU hand sanitiser

2017

The US Environmental Protection Agency grant the approval of Byotrol’s proprietary 24-hour germ-kill surface sanitizer

2018

Target Corporation launch the first Byotrol24 consumer product in the US

2018

Byotrol acquires Medimark Scientific Limited, a leading provider of biocide-based infection control products for the animal and human healthcare markets

2019

Byotrol sells patents and underlying IP to Solvay SA, whilst retaining rights to sell Actizone in finished product form; completes licences with two key suppliers into UK NHS – with SC Johnson Professional on alcohol free hand sanitisers; and with Tristel on (non-sporicidal) anti-microbial surface care chemistries

2020

Byotrol accelerates earnout payments relating to Medimark Scientific, allowing final integration of the two companies

2021

Byotrol achieves significant profitability; licences technology to transfer US operations to third party

2022

Byotrol centralises its commercial operations into Thornton Science Park, alongside the existing laboratory facilities